Dr. Shaida Khan, DO

Dr. Khan practices at James W Aston Ambulatory Care Center in Dallas, Texas.

Dr. Khan's NPI, 1346501350, was assigned on June 6, 2012. Dr. Khan graduated from Texas College of Osteopathic Medicine in 2012. Dr. Khan holds Texas license Q9399.

Dr. Khan's primary practice is James W Aston Ambulatory Care Center, at 5303 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-2300.

Dr. Khan's primary practice is James W Aston Ambulatory Care Center in Dallas, Texas. Dr. Khan is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Khan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Khan is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Khan is licensed in Texas.

Dmand AI lists hereditary polyneuropathy, hypersomnia, muscle disease, muscle weakness, neck pain and spine problems, neuropathy and seizures among the conditions Dr. Khan treats.

CMS data shows 188 Medicare services from Dr. Khan across 6 procedure codes in 2024, for 136 Medicare patients. Medicare paid $17,596 for them.

CMS counts 136 Medicare patients who saw Dr. Khan in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 57, with 53% women.

In 2024, Dr. Khan wrote 1,031 Medicare Part D claims for 138 patients. 74% of them were for generic drugs. CMS names the drug for 831 of them, across 21 drugs with 11 or more claims each, at $3,678,254 in total drug cost. In 2023, CMS named 827 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Khan for performance year 2024, reported as part of a group. Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khan as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Khan, published from 2014 to 2025. 2014 was the busiest year, with 2. Dr. Khan's most frequent co-authors are Michael Benatar, MD, Kyle Matthew Blackburn, MD and Tahseen Mozaffar, MD.

Dmand AI links Dr. Khan to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Myasthenia Gravis and Neuromuscular Junction Diseases.

CMS Open Payments shows 30 general payments to Dr. Khan from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. UCB, Inc. paid the most, $25,207.

Dmand AI lists 4 awards for Dr. Khan, most recently UTSW Wellstone MDCRC Training Grant in 2018.

Dr. Khan graduated from Texas College of Osteopathic Medicine in 2012. Dr. Khan is a member of AOA, AAN and AOA.

Dr. Khan is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.